Abstract
Effects of medetomidine (40μg/kg)-midazolam (0.2mg/kg) on plasma glucose and insulin concentrations were evaluated in laboratory pigs. Intramuscular injection of medetomidine-midazolam induced a gradual hyperglycemic response associated with hypoinsulinemia which was much smaller than that by 80μg/kg of medetomidine alone and was almost within a physiological fluctuation. These mild responses induced by medetomidine-midazolam were antagonized by use of an α2-adrenoreceptor antagonist atipamezole (160μg/kg), therefore those changes were thought to be mainly attributed to the effect of medetomidine on α2-adrenoreceptors. A combination of medetomidine at a low dose and midazolam reduces undesirable effects, while providing more profound sedation than medetomidine alone in laboratory pigs.
